Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah D Burnett

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|February 22, 2021
Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterizationSarah D Burnett, Alexander D Blanchette, Weihsueh A Chiu, et al.
Journal of Pharmacological and Toxicological Methods|January 9, 2022
A tiered approach to population-based in vitro testing for cardiotoxicity: Balancing estimates of potency and variabilityAlexander D Blanchette, Sarah D Burnett, Ivan Rusyn, et al.
Chemical Research in Toxicology|August 27, 2021
Cardiotoxicity Hazard and Risk Characterization of ToxCast Chemicals Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Multiple DonorsSarah D Burnett, Alexander D Blanchette, Weihsueh A Chiu, et al.
Journal of Toxicology and Environmental Health. Part A|August 24, 2021
A new approach method for characterizing inter-species toxicodynamic variabilitySarah D Burnett, Moumita Karmakar, William J Murphy, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 20, 2020
A Bayesian Method for Population-wide Cardiotoxicity Hazard and Risk Characterization Using an In Vitro Human ModelAlexander D Blanchette, Sarah D Burnett, Fabian A Grimm, et al.
Regulatory Toxicology and Pharmacology : RTP|March 6, 2024
Evaluating scientific confidence in the concordance of in vitro and in vivo protective points of departureEn-Hsuan Lu, Lucie C Ford, Zunwei Chen, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
A Deep Learning-Based Scoring Framework for Large-Scale Multi-Donor Cardiotoxicity ScreeningDanny Vu, Andrew Kowalczewski, Sarah D Burnett, et al.
Chemical Research in Toxicology|July 24, 2024
Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human-Induced Pluripotent Stem-Cell-Derived CardiomyocytesHan-Hsuan D Tsai, Lucie C Ford, Sarah D Burnett, et al.
Toxicology and Applied Pharmacology|August 20, 2019
Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytesSarah D Burnett, Alexander D Blanchette, Fabian A Grimm, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 26, 2014
Persistence of furan-induced epigenetic aberrations in the livers of F344 ratsAline de Conti, Tetyana Kobets, Volodymyr Tryndyak, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Metabolism & Toxicology|February 22, 2021
Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterizationSarah D Burnett, Alexander D Blanchette, Weihsueh A Chiu, et al.
Journal of Pharmacological and Toxicological Methods|January 9, 2022
A tiered approach to population-based in vitro testing for cardiotoxicity: Balancing estimates of potency and variabilityAlexander D Blanchette, Sarah D Burnett, Ivan Rusyn, et al.
Chemical Research in Toxicology|August 27, 2021
Cardiotoxicity Hazard and Risk Characterization of ToxCast Chemicals Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Multiple DonorsSarah D Burnett, Alexander D Blanchette, Weihsueh A Chiu, et al.
Journal of Toxicology and Environmental Health. Part A|August 24, 2021
A new approach method for characterizing inter-species toxicodynamic variabilitySarah D Burnett, Moumita Karmakar, William J Murphy, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 20, 2020
A Bayesian Method for Population-wide Cardiotoxicity Hazard and Risk Characterization Using an In Vitro Human ModelAlexander D Blanchette, Sarah D Burnett, Fabian A Grimm, et al.
Regulatory Toxicology and Pharmacology : RTP|March 6, 2024
Evaluating scientific confidence in the concordance of in vitro and in vivo protective points of departureEn-Hsuan Lu, Lucie C Ford, Zunwei Chen, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
A Deep Learning-Based Scoring Framework for Large-Scale Multi-Donor Cardiotoxicity ScreeningDanny Vu, Andrew Kowalczewski, Sarah D Burnett, et al.
Chemical Research in Toxicology|July 24, 2024
Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human-Induced Pluripotent Stem-Cell-Derived CardiomyocytesHan-Hsuan D Tsai, Lucie C Ford, Sarah D Burnett, et al.
Toxicology and Applied Pharmacology|August 20, 2019
Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytesSarah D Burnett, Alexander D Blanchette, Fabian A Grimm, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 26, 2014
Persistence of furan-induced epigenetic aberrations in the livers of F344 ratsAline de Conti, Tetyana Kobets, Volodymyr Tryndyak, et al.
Pageof 1